Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer. (Q40087664)
Jump to navigation
Jump to search
scientific article published on 18 August 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer. |
scientific article published on 18 August 2017 |
Statements
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer (English)
Atanasio Pandiella
MohammadA Sabbaghi
Gabriel Gil-Gómez
Cristina Guardia
Sonia Servitja
Montserrat Arumi-Uria
Laia Serrano
Marta Salido
Sandra Zazo
Cristina Chamizo
Paula González-Alonso
Juan Madoz-Gúrpide
Pilar Eroles
Ignasi Tusquets
Ana Rovira
Joan Albanell
Oriol Arpí
Silvia Menendez
Maria Martínez-García